Heparinized bovine pericardium as a novel cardiovascular bioprosthesis

Biomaterials

Volumn 21, Issue 22, 2000, Pages 2323-2330

  Lee, Won Kyu ^a   Park, Ki Dong ^a   Keun Han, Dong ^a   Suh, Hwal ^b   Park, Jong Chul ^b   Kim, Young Ha ^a  

^a Korea Institute of Science and Technology   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Anticalcification; Bovine pericardium; Heparin; Tissue patch

Indexed keywords

CALCIFICATION (BIOCHEMISTRY); COLLAGEN; ENZYMES; TISSUE; TOXICITY;

ANTICALCIFICATION; CYTOTOXICITY;

HEART VALVE PROSTHESES;

AMINOSUGAR; BIOMATERIAL; HEPARIN;

ANIMAL TISSUE; ARTICLE; BIOPROSTHESIS; CATTLE; HEPARINIZATION; NONHUMAN; PERICARDIUM; PRIORITY JOURNAL;

ANIMALS; BIOPROSTHESIS; BLOOD VESSEL PROSTHESIS; CATTLE; CELL DIVISION; CELL SURVIVAL; CELLS, CULTURED; COLLAGENASES; CROSS-LINKING REAGENTS; GLUTARAL; HEART VALVE PROSTHESIS; HEAT; HEPARIN; MALE; PERICARDIUM; RATS; RATS, SPRAGUE-DAWLEY; TENSILE STRENGTH;

ANIMALIA; BOS TAURUS; BOVINAE;

EID: 0342844543     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(00)00159-9     Document Type: Article

References (50)

1. Chvapil M, Kronenthal RL, Van Winkle Jr W. Medical surgical applications of collagen. In: Hall DA, Jacson DS, editors. International review of connective tissue research, vol. 6, chapter 1. London, New York: Academic Press, 1970. p. 1-61.
2. Holl-Allen R.T.J. Porcine dermal implants in man. J R Coll Surg Edinb. 29:1984;151-153.
3. Holl-Allen R.T.J. Porcine dermal repair of inguinal hernias. J R Coll Surg Edinb. 29:1984;154-157.
4. Colin W., Donoff R.B. Nerve regeneration through collagen tubes. J Dent Res. 63:1984;987-993.
5. Burke K.E., Naughton G., Waldo E., Cassai N. Bovine collagen implant. histologic chronology in pig dermis J Dermatol Surg Oncol. 9:1983;889-895.
6. DeLustro F., Smith S.T., Sundsmo J., Salem G., Kincaid S., Ellingsworth L. Reaction to injectable collagen. results in animal models and clinical use Plast Reconstr Surg. 79:1987;581-592.
7. Yannas I.V., Burke J.F. Design of an artificial skin. I. Basic design principles. J Biomed Mater Res. 14:1980;65-81.
8. Chvapil M. Considerations on manufacturing principles of a synthetic burn dressing. a review J Biomed Mater Res. 16:1982;245-263.
9. Pruitt B.A., Levine N.S. Characteristics and uses of biologic dressings and skin sulstitute. Arch Surg. 119:1984;312-322.
10. Bradley W.G., Wilkes G.L. Some mechanical property considerations of reconstituted collagen for drug release supports. Biomater Med Dev Art Org. 5:1977;159-175.
11. Weiger A.L., Carpenter-Green S.S., Soehgen E.C., Lenk R.P., Popescu M.C. Liposome-collagen gel matrix. a novel sustained drug delivery system J Pharm Sci. 74:1985;922-925.
12. O'Brien T.P., Sawusch M.R., Dick J.J., Hamburg T.R., Gottch J.D. Use of topical tobramycin. J Cataract Refract Surg. 14:1988;505-507.
13. Geggel H.S., Friend J., Thoft R.A. Collagen gel for ocular surface. Invest Ophthalmol Vis Sci. 26:1985;901-905.
14. Tanner J.C., Marcucci M.A., Bradly W.H., Morgan J.W. Partial nephrectomy and use of collagen graft for renal wound closure. J Urol. 109:1968;710-712.
15. Nimni M.E., Cheung D., Strates B., Kodama M., Sheikh K. Chemically modofied collagen. a natural biomaterial for tissue replacement J Biomed Mater Res. 21:1987;741-771.
16. Chvapil M, Kronenthal RL, van Winkle Jr W. Medical and surgical applications of collagen. In: Hall DA, Jackson DS, editors. International review of connective tissue research, vol. 6, chapter 1. London, New York: Academic Press, 1970. p. 1-61.
17. Menasche P., Flaud P., Huc A. Co, Piwnica A. Collagen vascular grafts. a step towasds improved compliance in small-calibre bypass surgery: preliminary report Life Support Systems. 2:1984;233-237.
18. Weinberg C.P., Bell E. A blood vessel model constructed from aollagen and cultured vascular cells. Science. 231:1986;397-400.
19. Ishihara T., Ferans V.J., Jones M., Boyce S.W., Roberts W.C. Structure of bovine parietal pericardium and of unimplanted Ionescu-Shiley pericardial valvular bioprostheses. J Thorac Cardiovasc Surg. 81:1981;747-757.
20. Loop F.D., Crosgrove D.M., Kramer J.R. Late clinical and arteriographic results in 500 coronary artery reoperations. J Thorac Cardivasc Surg. 81:1981;675-684.
21. Milgalter E., Uretzky G., Siberman S. Pericardial meshing. An effective method for prevention of pericardial adhesions and epicardial reaction after cardiac operations. J Thorac Cardivasc Surg. 90:1985;281-286.
22. Culliford A.T., Spencer F.C. Guidelines for safty opening a previous sternomy incision. J Thorac Cardivasc Surg. 78:1979;633-638.
23. Schen F.J., Collins J.J., Cohn L.H. Long-term failure rate and morphologic correlations in porcine bioprosthetic heart valves. Am J Cardiol. 51:1983;957-964.
24. Levy R.J., Schoen F.J., Levy J.T., Nelson A.C., Howard S.L., Oshry L.J. Biologic determinants of dystrophic calcification and osteocalcin deposition in glutaraldehyde-preserved porcine aortic valve leaflets implanted subcutaneously in rats. Am J Pathol. 113:1993;143-155.
25. Ferrans V.J., Boyce S.W., Billingham M.E., Jones M., Ishihara T., Robert W.C. Calcific deposits in porcine bioprostheses: structure and pathogenesis. Am J Cardiol. 46:1980;721-734.
26. Thubrikar M.J., Deck J.D., Aouad J., Nolan S.P. Role of mechanical stress in calcification of aortic heart velves. J Thorac Cardivasc Surg. 86:1983;115-125.
27. Levy R.J., Schoen F., Anderson H.C. The identification of the vitamin K dependent bone protein, osteocalcin, as one of the γ-carboxglutarmic acid containing proteins present in calcified atheosclerotic plaque. Atherosclerosis. 46:1983;49-56.
28. Johnston T.P., Bove E.L., Bolling S.F. Controlled release of 1-hydroxyethylidene diphosphonate: in vitro assessment and effects on bioprostic calcification in sheep tricuspid valve replacement. Int J Phamaceut. 52:1989;139-148.
29. 3+ and aminodiphosphonate preincubations. Am J Pathol. 141:1992;487-496.
30. Hirsch D., Drader J., Yhomas T.J., Schoen F.J., Levy J.T., Levy R.J. Inhibition of calcification of glutaraldehyde pretreated porcine aortic valve cusps with sodium dodecyl sulfate: preincubation and coltrolled release studies. J Biomed Mater Res. 27:1993;1477-1484.
31. Chen W., Scheon F.J., Levy R.J. Mechanism of efficacy of 2-amino oleic acid for inhibition of calcification of glutaraldehyde pretreated porcine bioprosthetic heart valves. Circulation. 90:1994;323-329.
32. Nimni W.N., Cheung D., Strates B. Chemically modified collagen: a natural biomaterial for tissue replacement. J Biomed Mater Res. 15:1994;465-469.
33. Chanda J. Anticalcification treatment of pericardial prostheses. Biomaterials. 15:1994;465-469.
34. Pereira C.A., Lee J.M., Haberer S.A. Effect of alternative crosslinking methods on the low strain rate viscoelastic properties of bovine pericardial bioprosthetic material. J Biomed Mater Res. 24:1990;345-361.
35. Zimmermann B. Changes in glycosaminoglycan binding to collagen during desmoid mineralization as revealed by different electron microscopic staining techniques. 145:1992;277-282.
36. Park K.D., Lee W.K., Yun J.Y., Han D.K., Kim S.H., Kim Y.H., Kim H.M., Kim K.T. Novel anti-calcification treatment of biological tissue by grafting of sulfonated poly(ethylene oxide). Biomaterials. 18:1996;47-51.
37. Han DK, Lee NY, Park KD, Jeong SY, Kim YH, Cho Min BG. Heparin-like anti-coagulant activity of sulfonated poly(ethylene oxide) and sulfonated poly(ethylene oxide)-grfted polyurethane. Biomaterials 1995;16:467-471.
38. Park K.D., Yun J.Y., Han D.K., Kim S.H., Kim Y.H., Kim H.M., Kim K.T. Chemical modification of implantable biological tissue for anti-calcification. ASAIO J. 40:1994;M377-M382.
39. ISO 10993. Biological evaluation for medical device, part 5. Test for cytotoxicity: in vitro methods, 1992.
40. Woodroof E.A. The chemistry and biology of aldehyde treated tissue heart valves. Ionescu M.I. Tissue heart valves. 1979;347-362 Butterworth, London.
41. Cheung D.T., Nimni W.E. Mechanism of crosslinking of proteins by glutaraldehyde. I: reaction with model compounds. Connect Tissue Res. 10:1982;187-199.
42. Cheung D.T., Nimni W.E. Mechanism of crosslinking of proteins by glutaraldehyde. II: reaction with monomeric and polymeric collagen. Connect Tissue Res. 10:1982;201-216.
43. Cheung D.T., Perelman N., Ko E.C., Nimni M.E. Mechanism of crosslinking of proteins by glutaraldehyde. III: reactions with collagen in tissue. Connect Tissue Res. 13:1982;109-115.
44. Chanda J. Prevention of calcification of heart valve bioprostheses: an experimental study in rat. Ann Thorac Surg. 60:1995;S339-S342.
45. Chanda J., Kuribayashi R.K., Abe T. Heparin in calcification prevention of porcine pericardial bioprostheses. Biomaterials. 18:1997;1109-1113.
46. Rosengerg R.D. The function and structure of the heparin molecule. Witt Heparin: new biochemical and medical aspects. 1983;3-27 Walter de Gruyter, Berlin.
47. Park K.D., Kim W.G., Jacobs H., Okano T., Kim S.W. Blood compatibility of SPUU-PEO-heparin graft copolymers. J Biomed Mater Res. 26:1992;739-756.
48. Piao A.Z., Jacobs H., Park K.D., Kim S.W. Heparin immobilization via surface amplification. ASAIO J. 38:1992;638-643.
49. Noishiki Y., Miyata T.A. A simple method to heparinize biological materials. J Biomed Mater Res. 20:1986;337-346.
50. Sung H.W., Chang Y., Chiu Y.T., Hsu H.L., Shin C.C., Lu J.H., Yang P.C. Evaluation of an epoxy fixed biological patch with ionically bound heparin as a pericarial substitute. Biomaterials. 17:1996;1693-1701.